Literature DB >> 19706711

Preinfection human immunodeficiency virus (HIV)-specific cytotoxic T lymphocytes failed to prevent HIV type 1 infection from strains genetically unrelated to viruses in long-term exposed partners.

Yi Liu1, Amanda Woodward, Haiying Zhu, Thomas Andrus, John McNevin, Jean Lee, James I Mullins, Lawrence Corey, M Juliana McElrath, Tuofu Zhu.   

Abstract

Understanding the mechanisms underlying potential altered susceptibility to human immunodeficiency virus type 1 (HIV-1) infection in highly exposed seronegative (ES) individuals and the later clinical consequences of breakthrough infection can provide insight into strategies to control HIV-1 with an effective vaccine. From our Seattle ES cohort, we identified one individual (LSC63) who seroconverted after over 2 years of repeated unprotected sexual contact with his HIV-1-infected partner (P63) and other sexual partners of unknown HIV-1 serostatus. The HIV-1 variants infecting LSC63 were genetically unrelated to those sequenced from P63. This may not be surprising, since viral load measurements in P63 were repeatedly below 50 copies/ml, making him an unlikely transmitter. However, broad HIV-1-specific cytotoxic T-lymphocyte (CTL) responses were detected in LSC63 before seroconversion. Compared to those detected after seroconversion, these responses were of lower magnitude and half of them targeted different regions of the viral proteome. Strong HLA-B27-restricted CTLs, which have been associated with disease control, were detected in LSC63 after but not before seroconversion. Furthermore, for the majority of the protein-coding regions of the HIV-1 variants in LSC63 (except gp41, nef, and the 3' half of pol), the genetic distances between the infecting viruses and the viruses to which he was exposed through P63 (termed the exposed virus) were comparable to the distances between random subtype B HIV-1 sequences and the exposed viruses. These results suggest that broad preinfection immune responses were not able to prevent the acquisition of HIV-1 infection in LSC63, even though the infecting viruses were not particularly distant from the viruses that may have elicited these responses.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19706711      PMCID: PMC2753147          DOI: 10.1128/JVI.00839-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  64 in total

Review 1.  The effect of genetic variation in chemokines and their receptors on HIV transmission and progression to AIDS.

Authors:  S J O'Brien; J P Moore
Journal:  Immunol Rev       Date:  2000-10       Impact factor: 12.988

Review 2.  Polygenic and multifactorial disease gene association in man: Lessons from AIDS.

Authors:  S J O'Brien; G W Nelson; C A Winkler; M W Smith
Journal:  Annu Rev Genet       Date:  2000       Impact factor: 16.830

3.  Influence of HLA supertypes on susceptibility and resistance to human immunodeficiency virus type 1 infection.

Authors:  K S MacDonald; K R Fowke; J Kimani; V A Dunand; N J Nagelkerke; T B Ball; J Oyugi; E Njagi; L K Gaur; R C Brunham; J Wade; M A Luscher; P Krausa; S Rowland-Jones; E Ngugi; J J Bwayo; F A Plummer
Journal:  J Infect Dis       Date:  2000-05-08       Impact factor: 5.226

4.  HIV-1-specific mucosal CD8+ lymphocyte responses in the cervix of HIV-1-resistant prostitutes in Nairobi.

Authors:  R Kaul; F A Plummer; J Kimani; T Dong; P Kiama; T Rostron; E Njagi; K S MacDonald; J J Bwayo; A J McMichael; S L Rowland-Jones
Journal:  J Immunol       Date:  2000-02-01       Impact factor: 5.422

5.  Genital herpes and public health: addressing a global problem.

Authors:  L Corey; H H Handsfield
Journal:  JAMA       Date:  2000-02-09       Impact factor: 56.272

6.  Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group.

Authors:  T C Quinn; M J Wawer; N Sewankambo; D Serwadda; C Li; F Wabwire-Mangen; M O Meehan; T Lutalo; R H Gray
Journal:  N Engl J Med       Date:  2000-03-30       Impact factor: 91.245

7.  A polymorphism in the regulatory region of the CC-chemokine receptor 5 gene influences perinatal transmission of human immunodeficiency virus type 1 to African-American infants.

Authors:  L G Kostrikis; A U Neumann; B Thomson; B T Korber; P McHardy; R Karanicolas; L Deutsch; Y Huang; J F Lew; K McIntosh; H Pollack; W Borkowsky; H M Spiegel; P Palumbo; J Oleske; A Bardeguez; K Luzuriaga; J Sullivan; S M Wolinsky; R A Koup; D D Ho; J P Moore
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

8.  HIV-1-specific cellular immune responses among HIV-1-resistant sex workers.

Authors:  K R Fowke; R Kaul; K L Rosenthal; J Oyugi; J Kimani; W J Rutherford; N J Nagelkerke; T B Ball; J J Bwayo; J N Simonsen; G M Shearer; F A Plummer
Journal:  Immunol Cell Biol       Date:  2000-12       Impact factor: 5.126

9.  Chemokine RANTES promoter polymorphism affects risk of both HIV infection and disease progression in the Multicenter AIDS Cohort Study.

Authors:  D H McDermott; M J Beecroft; C A Kleeberger; F M Al-Sharif; W E Ollier; P A Zimmerman; B A Boatin; S F Leitman; R Detels; A H Hajeer; P M Murphy
Journal:  AIDS       Date:  2000-12-01       Impact factor: 4.177

10.  Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study.

Authors:  M Dean; M Carrington; C Winkler; G A Huttley; M W Smith; R Allikmets; J J Goedert; S P Buchbinder; E Vittinghoff; E Gomperts; S Donfield; D Vlahov; R Kaslow; A Saah; C Rinaldo; R Detels; S J O'Brien
Journal:  Science       Date:  1996-09-27       Impact factor: 47.728

View more
  9 in total

1.  Regulatory T-Cell Activity But Not Conventional HIV-Specific T-Cell Responses Are Associated With Protection From HIV-1 Infection.

Authors:  Laura Pattacini; Jared M Baeten; Katherine K Thomas; Tayler R Fluharty; Pamela M Murnane; Deborah Donnell; Elizabeth Bukusi; Allan Ronald; Nelly Mugo; Jairam R Lingappa; Connie Celum; M Juliana McElrath; Jennifer M Lund
Journal:  J Acquir Immune Defic Syndr       Date:  2016-06-01       Impact factor: 3.731

2.  HIV vaccines: mosaic approach to virus diversity.

Authors:  Lawrence Corey; M Juliana McElrath
Journal:  Nat Med       Date:  2010-03       Impact factor: 53.440

Review 3.  Evidence for the innate immune response as a correlate of protection in human immunodeficiency virus (HIV)-1 highly exposed seronegative subjects (HESN).

Authors:  C Tomescu; S Abdulhaqq; L J Montaner
Journal:  Clin Exp Immunol       Date:  2011-03-17       Impact factor: 4.330

4.  Absence of reproducibly detectable low-level HIV viremia in highly exposed seronegative men and women.

Authors:  Eric Delwart; Flavien Bernardin; Tzong-Hae Lee; Valerie Winkelman; Chenglong Liu; Haynes Sheppard; Albert Liu; Ruth Greenblatt; Katryn Anastos; Jack DeHovitz; Marek Nowicki; Mardge Cohen; Elizabeth T Golub; Jason Barbour; Susan Buchbinder; Michael P Busch
Journal:  AIDS       Date:  2011-03-13       Impact factor: 4.177

5.  Innate activation of MDC and NK cells in high-risk HIV-1-exposed seronegative IV-drug users who share needles when compared with low-risk nonsharing IV-drug user controls.

Authors:  Costin Tomescu; Kelly E Seaton; Peter Smith; Mack Taylor; Georgia D Tomaras; David S Metzger; Luis J Montaner
Journal:  J Acquir Immune Defic Syndr       Date:  2015-03-01       Impact factor: 3.731

Review 6.  Receptor binding domain based HIV vaccines.

Authors:  Huan Liu; Wenwen Bi; Qian Wang; Lu Lu; Shibo Jiang
Journal:  Biomed Res Int       Date:  2015-01-15       Impact factor: 3.411

7.  Early Kinetics of the HLA Class I-Associated Peptidome of MVA.HIVconsv-Infected Cells.

Authors:  Nicola Ternette; Peter D Block; Álvaro Sánchez-Bernabéu; Nicola Borthwick; Elisa Pappalardo; Sultan Abdul-Jawad; Beatrice Ondondo; Philip D Charles; Lucy Dorrell; Benedikt M Kessler; Tomáš Hanke
Journal:  J Virol       Date:  2015-03-25       Impact factor: 5.103

Review 8.  NK Cells in Protection from HIV Infection.

Authors:  Nicole F Bernard; Khlood Alsulami; Erik Pavey; Franck P Dupuy
Journal:  Viruses       Date:  2022-05-25       Impact factor: 5.818

9.  Viral Characteristics Associated with the Clinical Nonprogressor Phenotype Are Inherited by Viruses from a Cluster of HIV-1 Elite Controllers.

Authors:  Concepción Casado; Sara Marrero-Hernández; Daniel Márquez-Arce; Sílvia Marfil; Laura de Armas-Rillo; Julià Blanco; Agustín Valenzuela-Fernández; Cecilio Lopez-Galíndez; María Pernas; Ferran Borràs-Grañana; Isabel Olivares; Romina Cabrera-Rodríguez; María-Soledad Valera; Philippe Lemey
Journal:  mBio       Date:  2018-04-10       Impact factor: 7.867

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.